 Home > Active Ingredient News > Drugs Articles > Notice on Public Solicitation of "Guiding Principles for Evaluation of Immune-Related Adverse Events in Anti-tumor Therapy (Draft for Comment)"

Notice on Public Solicitation of "Guiding Principles for Evaluation of Immune-Related Adverse Events in Anti-tumor Therapy (Draft for Comment)"

 Last Update: 2021-12-05
 Source: Internet
 Author: User

Tags

anti ssa

fda sampling guidelines

anti dementia drugs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Tumor immunotherapy is currently a hot spot in the development of new anti-tumor drugs.

In order to improve the scientificity and robustness of the determination of immune-related adverse events in clinical trials of anti-tumor therapy, improve the quality of safety data such as instructions, and strengthen the protection of patients participating in trials and post-marketing drugs, the industry has investigated and initially solicited expert opinions.

We sincerely welcome valuable comments and suggestions from all walks of life on the solicitation draft, and timely feedback to us for follow-up improvement

Please send your feedback to the mailbox of the following contact:

Contact: Lu Jun, Zhou Ming

Contact: lvj@cde.

Thank you for your participation and great support

Drug Evaluation Center of the State Drug Administration

November 26, 2021

1 "Technical Guidelines for Evaluation of Immune-related Adverse Events in Anti-tumor Therapy (Draft for Solicitation of Comments)".

2 "Technical Guidelines for Evaluation of Immune-related Adverse Events in Anti-tumor Therapy (Draft for Comment)" feedback form.
docx

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Reta 5mg 10mg 15mg Vial Weight Loss Anti-diabetes Fat Loss

CAS No.: 2381089-83-2

Pharmacy Grade

$110-130/UNIT FOB

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Hot Sale 1-Adamantanamine Hydrochloride /1-Adamantanamine HCl CAS 665-66-7

CAS No.: 665-66-7

Pharmacy Grade

$20-25/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

united states logo(227)

ups united states(221)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.